Home › Research › Health systems and care delivery
1414-P: Characteristics Associated with Sulfonylureas and Basal Insulin Use following Metformin in Older Adults
Kristen DeCarlo, Matthew T. O’Brien, David T. Liss, Raymond H. Kang, Andrew Cooper, Manisha Cherupally, Emily D. Parker, Cassandra Aikman et al.. Diabetes, 2020-06-01
Topic: Brain proteins, microglia and lab models
Further research is needed to elucidate factors underlying differences in SFU and BI prescribing patterns. O’Brien: Research Support; Self; UnitedHealth Group. Kang: Research Support; Self; UnitedHealth Group. Ackermann: Research Support; Self; National Institute of Diabetes and Digestive and Kidney Diseases, UnitedHealth Group. Wallia: Research Support; Self; Eli Lilly and Company, Novo Nordisk Inc., UnitedHealth Group.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
DeCarlo, K., O’Brien, M. T., Liss, D. T., Kang, R. H., Cooper, A., Cherupally, M., et al. (2020). 1414-P: Characteristics Associated with Sulfonylureas and Basal Insulin Use following Metformin in Older Adults. Diabetes. https://doi.org/10.2337/db20-1414-p
Vancouver
DeCarlo K, O’Brien MT, Liss DT, Kang RH, Cooper A, Cherupally M, et al. 1414-P: Characteristics Associated with Sulfonylureas and Basal Insulin Use following Metformin in Older Adults. Diabetes. 2020. doi:10.2337/db20-1414-p.
BibTeX
@article{decarlo2020-f7466f98,
author = {DeCarlo, Kristen and O’Brien, Matthew T. and Liss, David T. and Kang, Raymond H. and Cooper, Andrew and Cherupally, Manisha and Parker, Emily D. and Aikman, Cassandra and others},
title = {{1414-P: Characteristics Associated with Sulfonylureas and Basal Insulin Use following Metformin in Older Adults}},
journal = {Diabetes},
year = {2020},
doi = {10.2337/db20-1414-p},
url = {https://doi.org/10.2337/db20-1414-p}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Further research is needed to elucidate factors underlying differences in SFU and BI prescribing patterns.
- O’Brien: Research Support; Self; UnitedHealth Group.
- Kang: Research Support; Self; UnitedHealth Group.
- Ackermann: Research Support; Self; National Institute of Diabetes and Digestive and Kidney Diseases, UnitedHealth Group.
- Wallia: Research Support; Self; Eli Lilly and Company, Novo Nordisk Inc., UnitedHealth Group.
Why it matters
This abstract concerns prescribing patterns of sulfonylureas and basal insulin after metformin in older adults with diabetes. It contains no information about treating, curing, or preventing Alzheimer's disease.
Study details
- Participants45,734
- Effect sizeOR1.08; OR1.2; OR1.35
- Evidence strengthLow
How this study scored 36/100
Published in a peer-reviewed journal. Scored zero for study design and randomised / blinded because the record does not state it. We have no data on institution's track record, so that was left out: it earned 35 of the 97 points we could judge it on, which is 36 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Diabetes) |
| Journal's citation record | 3 / 4 | Diabetes: journal h-index 447 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2020 — within 10 year(s) of the newest study here |
| Sample size | 4 / 4 | 45,734 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomised / blinded | 0 / 2 | No randomisation or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 8 year(s) since 2020 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Amisha Wallia: h-index 32 (OpenAlex, whole career) |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multi-centre collaboration | 0 / 3 | OpenAlex lists 0 institution(s) in 0 countries — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 1 / 2 | Not in PubMed, but has a DOI |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 35 / 97 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 35 of the 97 points we could judge it on is 36 out of 100. |
| Total | 36 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Health systems and care delivery
Also tagged “palliative”
858 studies in the library carry the topic tag “palliative”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 858 tagged studies.